Regionally Advanced Squamous Cell Carcinoma of the Head and Neck

Drug	Drug Name	Drug Description
DB00002	Cetuximab	An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck.

Drug	Drug Name	Target	Type
DB00002	Cetuximab	Epidermal growth factor receptor	target
DB00002	Cetuximab	Low affinity immunoglobulin gamma Fc region receptor III-B	target
DB00002	Cetuximab	Complement C1q subcomponent subunit A	target
DB00002	Cetuximab	Complement C1q subcomponent subunit B	target
DB00002	Cetuximab	Complement C1q subcomponent subunit C	target
DB00002	Cetuximab	Low affinity immunoglobulin gamma Fc region receptor III-A	target
DB00002	Cetuximab	High affinity immunoglobulin gamma Fc receptor I	target
DB00002	Cetuximab	Low affinity immunoglobulin gamma Fc region receptor II-a	target

Drug	Drug Name	Phase	Status	Count